World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
75
Citations
18880
World Ranking
1990
National Ranking
975

Research.com Recognitions

  • 1998 - Society Citation Award, Infectious Diseases Society of America

Overview

Rachel Schneerson is affiliated with the National Institutes of Health in the United States. Their research primarily focuses on fields including Medicine and Biochemistry, Genetics and Molecular Biology. Within these broader areas, their work concentrates on subfields such as Infectious Diseases and Endocrinology.

Their research covers topics related to Escherichia coli research studies, viral gastroenteritis research and epidemiology, and Clostridium difficile and Clostridium perfringens research.

Schneerson has published work in Clinical Microbiology and Infection, where they contributed at least one paper. One notable recent publication is titled Threshold protective levels of serum IgG to Shigella lipopolysaccharide: re-analysis of Shigella vaccine trials data, published in 2022 in Clinical Microbiology and Infection.

Frequent coauthors in their research collaborations include:

  • Dani Cohen
  • Shai Ashkenazi
  • Nahid Farzam
  • Anya Bialik
  • Shiri Meron-Sudai

Rachel Schneerson received the Society Citation Award from the Infectious Diseases Society of America in 1998.

Best Publications

  • PREPARATION, CHARACTERIZATION , AND IMMUNOGENICITY OF HAEMOPHILUS INFLUENZAE TYPE b POLYSACCHARIDE- PROTEIN CONJUGATES

    Rachel Schneerson;Osmar Barrera;Ann Sutton;John B. Robbins

  • Use of a Staphylococcus aureus Conjugate Vaccine in Patients Receiving Hemodialysis

    Henry Shinefield;Steven Black;Ali Fattom;Gary Horwith

  • The efficacy of a Salmonella typhi Vi conjugate vaccine in two-to-five-year-old children.

    F Y Lin;V A Ho;H B Khiem;D D Trach

  • Perspective: Hypothesis: Serum IgG Antibody Is Sufficient to Confer Protection against Infectious Diseases by Inactivating the Inoculum

    John B. Robbins;Rachel Schneerson;Shousun C. Szu

  • PROTECTIVE ACTIVITY OF VI CAPSULAR POLYSACCHARIDE VACCINE AGAINST TYPHOID FEVER

    KeithP. Klugman;HendrikJ. Koornhof;Rachel Schneerson;Michel Cadoz

  • Polysaccharide-protein conjugates: a new generation of vaccines.

    John B. Robbins;Rachel Schneerson

  • Further Studies on the Immunogenicity of Haemophilus influenzae Type b and Pneumococcal Type 6A Polysaccharide-Protein Conjugates

    Chiayung Chu;Rachel Schneerson;John B. Robbins;Suresh C. Rastogi

  • Double-blind vaccine-controlled randomised efficacy trial of an investigational Shigella sonnei conjugate vaccine in young adults

    Dani Cohen;Dani Cohen;Shai Ashkenazi;Shai Ashkenazi;Manfred S Green;Manfred S Green;Michael Gdalevich

  • Form variation in Escherichia coli K1: determined by O-acetylation of the capsular polysaccharide.

    F Orskov;I Orskov;A Sutton;R Schneerson

  • Quantitative Measurement of “Natural” and Immunization-induced Haemophilus influenzas type b Capsular Polysaccharide Antibodies

    Unknown

  • Encapsulation and capsular types in isolates of Staphylococcus aureus from different sources and relationship to phage types.

    D Sompolinsky;Z Samra;W W Karakawa;W F Vann

  • Protein conjugates of synthetic saccharides elicit higher levels of serum IgG lipopolysaccharide antibodies in mice than do those of the O-specific polysaccharide from Shigella dysenteriae type 1.

    Vince Pozsgay;Chiayung Chu;Lewis Pannell;Jennifer Wolfe

  • Hypothesis for Vaccine Development: Protective Immunity to Enteric Diseases Caused by Nontyphoidal Salmonellae and Shigellae May Be Conferred by Serum IgG Antibodies to the O-Specific Polysaccharide of Their Lipopolysaccharides

    John B. Robbins;Chiayung Chu;Rachel Schneerson

  • Antibodies Elicited by a Cryptococcus neoformans-Tetanus Toxoid Conjugate Vaccine Have the Same Specificity as Those Elicited in Infection

    Arturo Casadevall;Jean Mukherjee;Jean Mukherjee;Sarvamangala J. N. Devi;Sarvamangala J. N. Devi;Rachel Schneerson;Rachel Schneerson

  • Quantitative and qualitative analyses of serum antibodies elicited in adults by Haemophilus influenzae type b and pneumococcus type 6A capsular polysaccharide-tetanus toxoid conjugates

    R. Schneerson;J. B. Robbins;J. C. Parke;C. Bell

  • Synthesis, characterization, and clinical evaluation of conjugate vaccines composed of the O-specific polysaccharides of Shigella dysenteriae type 1, Shigella flexneri type 2a, and Shigella sonnei (Plesiomonas shigelloides) bound to bacterial toxoids.

    D N Taylor;A C Trofa;J Sadoff;C Chu

  • Synthesis and immunologic properties in mice of vaccines composed of Staphylococcus aureus type 5 and type 8 capsular polysaccharides conjugated to Pseudomonas aeruginosa exotoxin A.

    A Fattom;R Schneerson;S C Szu;W F Vann

  • A newly discovered cholesteryl galactoside from Borrelia burgdorferi.

    Gil Ben-Menachem;Joanna Kubler-Kielb;Bruce Coxon;Alfred Yergey

  • Cryptococcus neoformans serotype A glucuronoxylomannan-protein conjugate vaccines: synthesis, characterization, and immunogenicity.

    S. J.N. Devi;R. Schneerson;W. Egan;T. J. Ulrich

  • Method for the serological typing of the capsular polysaccharides of Staphylococcus aureus.

    W W Karakawa;J M Fournier;W F Vann;R Arbeit

  • Immunity to disease caused by Hemophilus influenzae type b. II. Specificity and some biologic characteristics of "natural," infection-acquired, and immunization-induced antibodies to the capsular polysaccharide of Hemophilus influenzae type b.

    Rachel Schneerson;Louis P. Rodrigues;J. C. Parke;John B. Robbins

Frequent Co-Authors

John B. Robbins
John B. Robbins National Institutes of Health
Birger Trollfors
Birger Trollfors Sahlgrenska University Hospital
Teresa Lagergård
Teresa Lagergård University of Gothenburg
Joseph Shiloach
Joseph Shiloach National Institutes of Health
Evgeny Vinogradov
Evgeny Vinogradov National Research Council Canada
Mark A. Miller
Mark A. Miller University of California San Francisco Medical Center
Stephen H. Leppla
Stephen H. Leppla National Institutes of Health
Emil C. Gotschlich
Emil C. Gotschlich Rockefeller University
John A Robbins
John A Robbins University of California, Davis
David N. Taylor
David N. Taylor Johns Hopkins University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring related online degrees can broaden career opportunities in healthcare and research. Many students pivot from science backgrounds into healthcare roles by enrolling in online nursing programs for non nurses. These programs provide a solid foundation in patient care while leveraging prior scientific knowledge.

For individuals seeking rapid entry into nursing, the easiest absn programs to get into offer accelerated Bachelor of Science in Nursing options, ideal for those with a non-nursing bachelor’s degree. These streamlined paths allow quicker transitions into clinical roles.

If a quicker credential is preferred, many consider easy lpn programs to get into, which focus on practical nursing skills. These programs involve less time and offer entry-level positions that can lead to further advancement.

For advanced practice, the question of what is the easiest np program is common. Nurse Practitioner degrees typically build on foundational nursing education and open doors to specialized immunology-related care, including infectious disease management and immunotherapy.

Best Scientists Citing Rachel Schneerson

Trending Scientists